Ashish Khemka – APEA – Asia Pacific Enterprise Awards

Access to Healthy Life


Ashish Khemka

Chairman & Managing Director

Outstanding Category

Ashish Khemka

Chairman & Managing Director


Mr. Ashish Vijay Khemka is the Chairman and Managing Director of AMN Life Science Pvt. Ltd. (AMN Life), a leading and fast-growing Pharmaceutical manufacturing and export house offering Plethora of brands covering a wide range of therapies from both acute and chronic segments. The AMN Life range incorporates new age molecules in Nephrology, Oncology and Nutraceuticals segments. The company was incorporated in the year 2003 and its export operations commenced in the same year.

Prior to venturing into pharmaceutical industry, Mr. Ashish joined Trans Freight Container Corporation Ltd. a 100% export oriented (EOU) Marine Freight container manufacturing unit as management trainee after his graduation. With sheer dent of merit and enterprise, he gained expertise in the field and simultaneously acquired managerial, leadership skills and rapidly rose to the level of COO within short span of one year.

In his professional and entrepreneurial career, Mr. Ashish has acquired a fine grasp of the Pharmaceutical market and has established credibility and reliability in his dealings and that contributes to the success of the enterprise. He is passionate about AMN Life and ensures the Company is extremely professional in all departments of the business. His leadership quality holds great promise to the Company and the team of employees are extremely supportive of his vision to achieve success in the shortest possible time.

Mr. Ashish is a results-oriented Chairman and Managing Director, driven to manage costs and establish strategic mutually beneficial partnerships and relationships with users, vendors and service providers. He is also adept in creating strategic alliances with Industry leaders to effectively align with and support AMN Life’s key business initiatives. Besides, he excels at building and retaining high performance teams by hiring, developing and motivating skilled professionals.

AMN Colour Logo 01
AMN Life Science Pvt. Ltd.

Healthcare, Pharmaceutical & Biotechnology Industry
811 A-Wing, The Capital, Bandra Kurla Complex,
Bandra East, Mumbai-400051, India
Tel: +91-97-65039676
www.amnlife.com

Career Highlights

2003

  • Started AMN LIFE Science in the year 2003 at Mumbai.

2007

  • Under Shri Ashish’s leadership, the exports of AMN Life Science showed a y-o-y growth of more than 100%.

2017/2018

  • AMN Life Group hit a turnover of Rs. 250 Crore.

“Mr. Ashish’s innovation strategy involves streamlining an increasingly complex manufacturing system. This type of next-generation innovation wades through the growing sea of new ideas and emerges with the strategies that deliver a clear and focused value in the form of targeted Acquisitions and partnerships, personalised treatments, efficient outsourcing partners and properly integrated innovative technologies, but perhaps this statement has wider implications for today’s pharmaceutical industry.”

AMN Life is a 100% EOU pharma company that has developed a wide range of innovative formulations in various dosage forms. These formulations cater to the therapeutic needs for allergic disorder, bacterial and fungal infections, malaria, erectile dysfunction, Diabetes and Cardio-vascular diseases to name a few. Amihepa, Renoket, Avam, S-Valapro, Suncetin, Asita and Amcort are few of the AMN Life brands that command a leadership position in the covered markets. Present in 25 countries, AMN Life’s success holds dominant position in south East Asian market, poised to grow its presence to almost 150 countries across the globe.

Under the leadership of Mr. Ashish, the exports of AMN Life showed a year-on-year growth of more than 100% in financial year 2007 and bagged the Indian Exporters’ Excellence Award. Continuing its growth trajectory over the years, the Company bagged SME business excellence Awards and leading SMEs of India 2016 in the Pharmaceuticals sector.

Mr. Ashish’s innovative entrepreneurial skill resulted in Acquisitions of ASA LIFE, Singapore in year 2018 and many more acquisitions are planned along with setting up offices worldwide. In the immediate future, AMN Life is poised to grow to achieve a dominating presence in the European union with provision for In-licencing and out – licencing opportunities. Today the Group boasts of more than 10 Companies India and Overseas and registered the sales turnover of more than Rs. 250 Crore across the group companies.

The Entrepreneur strives to drive operational excellence in every department within his business. It is not an easy concept to quantify, and very difficult to explain in simple practical terms to operators of different departments, however, he managed to overcome these challenges. Besides, he always guides the team to justify and use cost-efficient technologies, to bring out top quality products that are economical and reliable.

Mr. Ashish’s innovation strategy involves streamlining an increasingly complex manufacturing system. This type of next-generation innovation wades through the growing sea of new ideas and emerges with the strategies that deliver a clear and focused value in the form of targeted Acquisitions and partnerships, personalised treatments, efficient outsourcing partners and properly integrated innovative technologies, but perhaps this statement has wider implications for today’s pharmaceutical industry.

He believes that, the practice of cranking out rapid-fire innovation in the form of new molecules with the hopes of finding the next blockbuster is being replaced by targeted innovation strategies that demonstrate actual patient value and reach that can be duplicated across an enterprise.

Under his leadership, AMN Life is currently eying the EU certification along with highly professional team of 200 plus professionals and available to consider new alliance opportunities in the uncontested zones of in In-licensing, co-promotion, revenue sharing and carved partnership opportunities.

Mr. Ashish has also undertaken challenging green initiatives, which is reflected throughout AMN Life’s Supply Chain. The issue of Pharmaceuticals in the Environment (what some call PIE) has garnered plenty of media attention, mostly negative in the past several years. Most of the concern with drugs in the environment revolves around consumers who either excrete un-metabolised active ingredients or dispose of unused medications into sewage systems. Under his leadership, AMN Life is able to ensure complete deactivation of waste residues by using alkaline solution before it is being sent to centralised insemination.

Mr. Ashish hopes to provide

Access to life,
Access to healthy life
for everyone.